OTCMKTS:FPMI FluoroPharma Medical (FPMI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About FluoroPharma Medical Stock (OTCMKTS:FPMI) Get FluoroPharma Medical alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview FluoroPharma Medical, Inc. is a clinical-stage molecular imaging company focused on the discovery, development and commercialization of positron emission tomography (PET) imaging agents for assessment of cardiovascular and pulmonary disease. The company’s radiotracer candidates are designed to enhance the non‐invasive detection and characterization of vulnerable plaque, myocardial perfusion and pulmonary inflammation, addressing significant unmet needs in cardiology and respiratory medicine. FluoroPharma’s lead product candidates include atherosclerotic plaque imaging agents and myocardial perfusion tracers labeled with fluorine-18, which offer the potential for wide distribution through commercial cyclotron networks. These proprietary PET agents are engineered to bind selectively to molecular targets associated with inflammation, cell death and ischemia. The company leverages its in-house radiochemistry expertise alongside collaborations with academic medical centers and contract manufacturing organizations to advance its pipeline through preclinical validation and early-phase clinical trials. Headquartered in Burlington, Massachusetts, FluoroPharma operates primarily in the United States, with plans to extend its clinical development partnerships internationally. The management team comprises professionals with extensive backgrounds in nuclear medicine, drug development and regulatory affairs. FluoroPharma seeks to position its novel imaging agents as next-generation tools for cardiologists and pulmonologists, enabling more precise diagnosis, risk stratification and therapy monitoring.AI Generated. May Contain Errors. Read More Receive FPMI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FluoroPharma Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FPMI Stock News HeadlinesFPMI FluoroPharma Medical, Inc.October 19, 2024 | seekingalpha.comNew 'Fluoro Fentanyl' considered 5 times more potent than normal dose, report saysJuly 19, 2023 | msn.comClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enforcing that means a $5.39 billion pot must be paid out to everyday Americans. See, virtually every AI model is built off stolen data...October 4 at 2:00 AM | Angel Publishing (Ad)FluoroPharma Medical IncAugust 29, 2022 | reuters.comFluoroPharma Medical Inc (FPMI)January 19, 2022 | nasdaq.comSee More Headlines FPMI Stock Analysis - Frequently Asked Questions How were FluoroPharma Medical's earnings last quarter? FluoroPharma Medical Inc. (OTCMKTS:FPMI) released its quarterly earnings data on Friday, August, 14th. The biopharmaceutical company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.01. How do I buy shares of FluoroPharma Medical? Shares of FPMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of FluoroPharma Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that FluoroPharma Medical investors own include Adicet Bio (ACET), Marin Software (MRIN), Aurora Cannabis (ACB), AB Corporate Bond ETF (EYEG), Designer Brands (DBI), Capricorn Energy (CNE) and Comcast (CMCSA). Company Calendar Last Earnings8/14/2015Today10/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:FPMI CIK1402785 Webwww.fluoropharma.com Phone(973) 744-1565FaxN/AEmployees4Year Founded2003Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:FPMI) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredLost Decade warning – do this nowWith the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter ...Porter & Company | SponsoredThe next biggest bull run in over 50 yearsGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FluoroPharma Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FluoroPharma Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.